Keefe Bruyette is positive on shares of Jefferson Capital (JCAP) heading into 2026. The firm reiterates an Outperform rating on the name with a $28 price target Jefferson is well positioned to benefit from a continued normalization in the U.S. and international credit cycle, the analyst tells investors in a research note. Keefe is “constructive” on industry fundamentals as supply increases and believes the company is “industry-leading cash efficiency ratio should continue to drive strong returns.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JCAP:
- Jefferson Capital management to meet virtually with Truist
- Jefferson Capital price target raised to $28 from $22 at Keefe Bruyette
- Jefferson Capital’s Earnings Call Highlights Growth
- Jefferson Capital price target raised to $26 from $23 at Citizens JMP
- Jefferson Capital Reports Strong Q3 2025 Financial Growth
